DIVA Laboratories, Ltd.
4153
Rank in Stocks
#22377
DIVA Laboratories, Ltd. specializes in the global provision of advanced display... DIVA Laboratories, Ltd. specializes in the global provision of advanced display technologies. Its comprehensive product lineup caters to critical environments, including specialized endo/surgical displays designed to render both static and dynamic imagery with precision for hybrid and integrated operating theaters, as well as crucial control room applications. Furthermore, DIVA offers a range of color and monochrome monitors tailored for high-accuracy radiology and broader medical imaging purposes. Beyond healthcare, the company develops interactive touch displays and human-machine interface (HMI) solutions, alongside robust medical and industrial enclosures. DIVA also serves original design manufacturers (ODMs) and original equipment manufacturers (OEMs) with custom display units, in addition to a broader portfolio of video solutions. Established in 1995, DIVA Laboratories, Ltd. maintains its corporate headquarters in New Taipei City, Taiwan.
Share Price
$0.92672755
Last synced: 2026-11-10
Market Cap
$54.37M
Change (1 day)
-1.78%
Change (1 year)
-14.64%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DIVA Laboratories, Ltd. (4153)
Category
Healthcare
EPS for DIVA Laboratories, Ltd. (4153)
EPS as of September 2026 TTM: $0.06
According to DIVA Laboratories, Ltd.'s latest financial reports, its current EPS (TTM) is $0.06. At the end of 2025 the company had an EPS of $0.05, equal to its 2024 EPS of $0.05.
EPS history for DIVA Laboratories, Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.06 | 19.80% |
| 2025 | $0.05 | 0.82% |
| 2024 | $0.05 | 19.66% |
| 2023 | $0.04 | 46.93% |
| 2022 | $0.03 | 108.27% |
| 2021 | $0.01 | 43.01% |
| 2020 | $0.01 | -64.37% |
| 2019 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | 31,602.84% |
US
|
|
| $6.12 | 10,117.03% |
US
|
|
| $1.38 | 2,199.00% |
CN
|
|
| $14.83 | 24,657.93% |
US
|
|
| $5.09 | 8,397.50% |
US
|
Questions about DIVA Laboratories, Ltd.'s earnings per share (EPS)
What is DIVA Laboratories, Ltd.'s earnings per share (EPS)?
DIVA Laboratories, Ltd.'s earnings per share (EPS) over the last twelve months is $0.06, as of Sep 2026.
What was DIVA Laboratories, Ltd.'s earnings per share (EPS) in 2025?
In 2025, DIVA Laboratories, Ltd.'s earnings per share (EPS) was $0.05, about the same as in 2024 ($0.05).
How has DIVA Laboratories, Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, DIVA Laboratories, Ltd.'s earnings per share (EPS) went from $0.01 to $0.05, an average growth of 37.97% a year.
How does DIVA Laboratories, Ltd.'s earnings per share (EPS) compare with similar companies?
DIVA Laboratories, Ltd.'s earnings per share (EPS) ($0.06) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.